Ethan A. Kohn
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
Papers in
- Oncology 9
- Cancer Cells and Metastasis 5
- Cancer-related Molecular Pathways 4
-
- DNA Repair Mechanisms 3
- TGF-β signaling in diseases 3
- Cancer therapeutics and mechanisms 2
- Angiogenesis and VEGF in Cancer 1
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Alan Eastman (3 shared papers)Max S. Wicha (1 shared paper)P. Bagavandoss (1 shared paper)Lalage M. Wakefield (5 shared papers)Jeong‐Seok Nam (3 shared papers)Mi‐Jin Kang (2 shared papers)Mark Livingstone (2 shared papers)Binwu Tang (3 shared papers)
- Journals
- Cancer Research (2 papers)Cancer Letters (1 paper)Journal of Biological Chemistry (1 paper)Proceedings of the National Academy of Sciences (1 paper)Molecular Cancer Research (1 paper)
- Partner nations
- United StatesSouth KoreaMalaysia
In The Last Decade
Ethan A. Kohn
10 papers receiving 771 citations
Peers
Comparison fields: 5 of 77
- Oncology 368
- Immunology and Allergy 55
- Molecular Biology 487
- Cell Biology 109
- Cancer Research 84
Countries citing papers authored by Ethan A. Kohn
This map shows the geographic impact of Ethan A. Kohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ethan A. Kohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ethan A. Kohn more than expected).
Fields of papers citing papers by Ethan A. Kohn
This network shows the impact of papers produced by Ethan A. Kohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ethan A. Kohn. The network helps show where Ethan A. Kohn may publish in the future.
Co-authors
The 25 scholars most cited alongside Ethan A. Kohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1982 | 216 | |
| 2 | 2008 | 190 | |
| 3 | The protein kinase C inhibitor Gö6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints. | 2003 | 114 |
| 4 | 2006 | 92 | |
| 5 | 2002 | 90 | |
| 6 | A novel indolocarbazole, ICP-1, abrogates DNA damage-induced cell cycle arrest and enhances cytotoxicity: similarities and differences to the cell cycle checkpoint abrogator UCN-01. | 2002 | 34 |
| 7 | 2009 | 30 | |
| 8 | 2010 | 22 | |
| 9 | 2012 | 20 | |
| 10 | The Cellular Microenvironment | 2004 | 1 |
About Ethan A. Kohn
Ethan A. Kohn is a scholar working on Oncology, Molecular Biology, Surgery, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 10 papers that have together received 809 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Cancer-related Molecular Pathways (4 papers), DNA Repair Mechanisms (3 papers), TGF-β signaling in diseases (3 papers), Cancer therapeutics and mechanisms (2 papers), Angiogenesis and VEGF in Cancer (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Digestive system and related health (1 paper). The work is most often cited by research in Oncology (368 citations), Immunology and Allergy (55 citations), Molecular Biology (487 citations), Cell Biology (109 citations) and Cancer Research (84 citations). Ethan A. Kohn has collaborated with scholars based in United States, South Korea and Malaysia. Frequent co-authors include Alan Eastman, Max S. Wicha, P. Bagavandoss, Lalage M. Wakefield, Jeong‐Seok Nam, Mi‐Jin Kang, Mark Livingstone, Binwu Tang, Christina H. Stuelten and Miriam R. Anver. Their work appears in journals such as Cancer Research, Cancer Letters, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences and Molecular Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.